August 24, 2021
Japanese drug makers’ operating profits are outpacing their full-year forecasts, with 22 companies racking up an average progression rate of 38.2% versus their annual guidance already in the April-June first quarter, according to a Jiho tally. These companies’ Q1 operating...read more